BGM Group Ltd.

BGM Group Ltd. (QLI) priced its initial public offering on Jan 12, 2021 at $5.00 per share, raising $25M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $175M. Hunter Taubman Fischer & Li, Ogier and Dentons advised the company and Ortoli Rosenstadt advised the underwriters.

BGM Group Ltd. is a China-based pharmaceutical and chemical company that develops, makes, markets and sells licorice products, oxytetracycline, traditional Chinese medicine derivatives, heparin, sausage casings and fertilizers. It developed Gan Di Xin and Ahan Antibacterial Paste and sells in more than 20 Chinese provinces.

Status

IPO

Ticker

QLI

Exchange

Nasdaq Global Market

Priced

Jan 12, 2021

IPO price

$5.00

Raised

$25M

Market cap at IPO price

$175M

First filed

Nov 4, 2019

Company counsel

Hunter Taubman Fischer & Li, Ogier and Dentons

Underwriters' counsel

Ortoli Rosenstadt

Sector

Biotech & pharma

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.